1. Home
  2. MRNA vs ALAB Comparison

MRNA vs ALAB Comparison

Compare MRNA & ALAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • ALAB
  • Stock Information
  • Founded
  • MRNA 2010
  • ALAB 2017
  • Country
  • MRNA United States
  • ALAB United States
  • Employees
  • MRNA N/A
  • ALAB N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • ALAB
  • Sector
  • MRNA Health Care
  • ALAB
  • Exchange
  • MRNA Nasdaq
  • ALAB NYSE
  • Market Cap
  • MRNA 10.6B
  • ALAB 10.6B
  • IPO Year
  • MRNA 2018
  • ALAB 2024
  • Fundamental
  • Price
  • MRNA $26.56
  • ALAB $90.10
  • Analyst Decision
  • MRNA Hold
  • ALAB Strong Buy
  • Analyst Count
  • MRNA 19
  • ALAB 15
  • Target Price
  • MRNA $48.13
  • ALAB $97.50
  • AVG Volume (30 Days)
  • MRNA 14.2M
  • ALAB 4.9M
  • Earning Date
  • MRNA 05-01-2025
  • ALAB 05-06-2025
  • Dividend Yield
  • MRNA N/A
  • ALAB N/A
  • EPS Growth
  • MRNA N/A
  • ALAB N/A
  • EPS
  • MRNA N/A
  • ALAB 0.26
  • Revenue
  • MRNA $3,177,000,000.00
  • ALAB $490,474,000.00
  • Revenue This Year
  • MRNA N/A
  • ALAB $79.74
  • Revenue Next Year
  • MRNA $8.98
  • ALAB $28.96
  • P/E Ratio
  • MRNA N/A
  • ALAB $361.44
  • Revenue Growth
  • MRNA N/A
  • ALAB 200.19
  • 52 Week Low
  • MRNA $23.15
  • ALAB $36.22
  • 52 Week High
  • MRNA $158.82
  • ALAB $147.39
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 50.60
  • ALAB N/A
  • Support Level
  • MRNA $25.22
  • ALAB N/A
  • Resistance Level
  • MRNA $27.15
  • ALAB N/A
  • Average True Range (ATR)
  • MRNA 1.61
  • ALAB 0.00
  • MACD
  • MRNA 0.26
  • ALAB 0.00
  • Stochastic Oscillator
  • MRNA 47.66
  • ALAB 0.00

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About ALAB ASTERA LABS INC

Astera Labs Inc designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform integrates semiconductor technology, microcontrollers, sensors, and software to enhance performance, scalability, and data management. The company offers products such as integrated circuits (ICs), boards, and modules, catering to hyperscalers and system OEMs. The company's solutions focus on data, network, and memory management in AI-driven platforms.

Share on Social Networks: